Publications have shown that all cases of Hairy Cell Leukaemia harbour the BRAF V600E variant. The analysis of BRAF V600E is a useful tool in the differential diagnosis of mature B-cell neoplasms.
In this programme, participants are provided with lyophilised cell-lines for BRAF V600E mutation status analysis. Participants are asked to submit qualitative results, together with details of the methodology. Instructions for storage, reconstitution and use of the lyophilised samples are included with the samples. Three send-outs are issued per annum, with each send-out consisting of two samples.
Periodically we give laboratories the option of returning quantitative results. Whilst this allows participants to compare their results with the trial statistics, it is not currently a compulsory part of the programme, nor is it subject to performance monitoring.
No activities in relation to this EQA programme are subcontracted.
To register for this programme, please click here.